Treatment of Larotaxel/Docetaxel, +/- Trastuzumab, After Anthracycline-cyclophosphamide in Breast Cancer Patients
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Neoplasms
Interventions: DRUG: larotaxel (XRP9881)|DRUG: docetaxel|DRUG: trastuzumab
Sponsor: Sanofi